Epilepsy
📧 Sign up to get email alerts when something new happens for Epilepsy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-10-01Clinical Trial Update: Massage Based on the Human Caring Model in Epilepsy [NA]
A completed clinical trial at Muş Alparslan University evaluated massage based on the Human Caring Model as a therapy for epilepsy.
-
CLINICAL_TRIALS research · 2025-10-01Clinical Trial Update: Novel Multimodal Neural, Physiological, and Behavioral Sensing and Machine Learning for Mental States [NA]
This clinical trial entry from the University of Southern California describes a study evaluating multimodal neural, physiological, and beha…
-
FDA approval · 2025-09-30FDA Approved: TEGRETOL XR — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for Tegretol XR (carbamazepine) submitted by Novartis Pharmaceuticals Corporation.
-
FDA approval · 2025-09-29FDA Approved: LAMOTRIGINE — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Lamotrigine from Zydus Pharmaceuticals USA Inc., resulting in clearance for a generic lamotrigin…
-
CLINICAL_TRIALS trial_result · 2025-09-26Clinical Trial Update: Efficacy of Naloxone in Reducing Postictal Central Respiratory Dysfunction in Patients With Epilepsy [Phase 3]
Phase 3 clinical trial evaluating whether naloxone can reduce postictal central respiratory dysfunction in epilepsy patients; the study has …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-09-24Clinical Trial Update: The Value of EEG in Stroke Units
A recruiting clinical trial evaluating the value of EEG in stroke unit care to monitor and guide seizure management in patients with epileps…
-
FDA approval · 2025-09-23FDA Approved: TRILEPTAL — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for TRILEPTAL (oxcarbazepine) submitted by Novartis Pharmaceuticals Corporation.
-
FDA approval · 2025-09-23FDA Approved: PRIMIDONE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for Primidone (generic) from Actavis Pharma, Inc., under ANDA083551.
-
CLINICAL_TRIALS research · 2025-09-23Clinical Trial Update: Rehabilitation of Cognition and Psychosocial Well-being in Epilepsy [NA]
This clinical trial update notes an ongoing study at Vilnius University examining rehabilitation of cognition and psychosocial well-being in…
-
CLINICAL_TRIALS research · 2025-09-22Clinical Trial Update: Spatial Memory and Temporal Lobe Epilepsy [NA]
A clinical trial update indicates a study on spatial memory and temporal lobe epilepsy is currently recruiting at Centre Hospitalier Metropo…
-
CLINICAL_TRIALS research · 2025-09-22Clinical Trial Update: Model-based Electrical Brain Stimulation [NA]
A clinical trial update from the University of Southern California about model-based electrical brain stimulation for medication-refractory …
-
CLINICAL_TRIALS research · 2025-09-22Clinical Trial Update: Contribution of Fast-ripples to the Improvement of the Neurosurgical Management of Drug-refractory Epilepsy [NA]
A clinical trial update on using fast ripples to improve neurosurgical management of drug-refractory epilepsy. The study is currently recrui…
-
CLINICAL_TRIALS research · 2025-09-22Clinical Trial Update: Social Cognition in Pediatric Epilepsy [NA]
A clinical trial sponsored by CHU de Reims is currently recruiting to study social cognition in children with epilepsy.
-
CLINICAL_TRIALS research · 2025-09-19Clinical Trial Update: Prognostic Value of High-resolution Electrical Source Imaging on the Success of Pediatric Focal Epilepsy Surgery [NA]
This trial investigates whether high-resolution electrical source imaging can predict the success of focal epilepsy surgery in children. It …
-
FDA approval · 2025-09-19FDA Approved: GABAPENTIN — Original Application (ScieGen Pharmaceuticals, Inc.)
FDA approved ScieGen Pharmaceuticals' original application for a generic gabapentin, enabling a generic version to be marketed for the same …
-
FDA approval · 2025-09-17FDA Approved: OXCARBAZEPINE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a supplemental application for Oxcarbazepine filed by Glenmark Pharmaceuticals Inc., USA.
-
CLINICAL_TRIALS research · 2025-09-17Clinical Trial Update: Low Intensity Focused Ultrasound Epilepsy: A Pilot Trial [NA]
An update on an ongoing pilot clinical trial evaluating low-intensity focused ultrasound for drug-resistant epilepsy, currently recruiting.
-
FDA approval · 2025-09-16FDA Approved: SUBVENITE — Original Application (OWP Pharmaceuticals, Inc.)
The FDA approved SUBVENITE (lamotrigine) through an Original Application filed by OWP Pharmaceuticals, Inc.
-
FDA approval · 2025-09-16FDA Approved: OXCARBAZEPINE — Supplemental Application (EPIC PHARMA, LLC)
FDA approved a supplemental application for oxcarbazepine submitted by Epic Pharma, LLC, authorizing a generic formulation under ANDA 215332…
-
CLINICAL_TRIALS trial_result · 2025-09-16Clinical Trial Update: Bioavailability of Stiripentol After Single Oral Dose of Capsule vs Suspension in Healthy Subjects (STILIQ) [Phase 1]
This Phase 1 trial evaluated the bioavailability of stiripentol after a single oral dose, comparing capsule administration to suspension in …
-
CLINICAL_TRIALS research · 2025-09-16Clinical Trial Update: The Neural Coding of Speech Across Human Languages [NA]
Clinical trial update for a UCSF study on the neural coding of speech across human languages, currently enrolling by invitation for particip…
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: Prospective Evaluation of Probabilistic Predictions of Epileptic Seizure Risk Using the EPIDAY Tool [NA]
The study will prospectively evaluate probabilistic predictions of epileptic seizure risk using the EPIDAY tool in individuals with epilepsy…
-
CLINICAL_TRIALS research · 2025-09-10Clinical Trial Update: Effect of Different Anesthetic Drugs on Electrocorticography (ECOG). [Phase 3]
Phase 3 clinical trial update evaluating how different anesthetic drugs influence electrocorticography in patients with epilepsy and brain t…
-
CLINICAL_TRIALS research · 2025-09-10Clinical Trial Update: Effect of Blue Light on Vagus Nerve Stimulation in Patients With Refractory Epilepsy [NA]
Clinical trial evaluating whether blue light exposure affects vagus nerve stimulation in patients with refractory epilepsy. The study is cur…
-
CLINICAL_TRIALS research · 2025-09-10Clinical Trial Update: Adjunctive Anti-seizure Medication (ASM) Real World Evidence (RWE) Study
Real-world evidence study evaluating adjunctive anti-seizure medication for epilepsy; the trial is currently active but not recruiting.